{"id":"placebo-with-hydrocodone-apap-prn","safety":{"commonSideEffects":[{"rate":"40-50","effect":"Constipation"},{"rate":"20-30","effect":"Nausea"},{"rate":"15-25","effect":"Dizziness"},{"rate":"20-30","effect":"Drowsiness"},{"rate":null,"effect":"Respiratory depression"},{"rate":null,"effect":"Hepatotoxicity (acetaminophen)"}]},"_chembl":{"chemblId":"CHEMBL1201470","moleculeType":"Small molecule"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Hydrocodone acts as a mu opioid receptor agonist, modulating pain signals in the brain and spinal cord. Acetaminophen works through inhibition of cyclooxygenase (COX) enzymes, reducing prostaglandin production. The combination provides synergistic analgesia for moderate pain. This formulation is being studied with placebo control in a VA research context.","oneSentence":"Hydrocodone is an opioid agonist that binds to mu opioid receptors in the central nervous system to reduce pain perception, while acetaminophen (APAP) inhibits prostaglandin synthesis to provide additional analgesic and antipyretic effects.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:33.710Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Moderate pain (acute or chronic pain conditions)"}]},"trialDetails":[{"nctId":"NCT03823534","phase":"PHASE3","title":"Post-Op Pain Control for Prophylactic Intramedullary Nailing.","status":"RECRUITING","sponsor":"St. Louis University","startDate":"2019-02-20","conditions":"Bone Metastases, Lymphoma, Multiple Myeloma","enrollment":60},{"nctId":"NCT02588027","phase":"NA","title":"Effect of Ibuprofen on Postoperative Opiate Medication Use and Shoulder Functional Outcomes","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2015-10","conditions":"Rotator Cuff Tear Arthropathy","enrollment":110},{"nctId":"NCT02929589","phase":"PHASE3","title":"Ibuprofen to Decrease Opioid Use and Post-operative Pain Following Unilateral Inguinal Herniorrhaphy","status":"TERMINATED","sponsor":"Mike O'Callaghan Military Hospital","startDate":"2018-07-05","conditions":"Pain, Hernia","enrollment":18},{"nctId":"NCT05800847","phase":"PHASE4","title":"Effect of Gabapentin on Sleep and Opioid Use Following Rotator Cuff Repair","status":"UNKNOWN","sponsor":"Hughston Clinic","startDate":"2023-04","conditions":"Rotator Cuff Tears","enrollment":130},{"nctId":"NCT02219581","phase":"PHASE4","title":"Steroids in Total Knee Arthroplasty","status":"TERMINATED","sponsor":"Thomas L Bradbury","startDate":"2014-10-16","conditions":"Postoperative Pain, Inflammation, Osteoarthritis","enrollment":1},{"nctId":"NCT02540512","phase":"EARLY_PHASE1","title":"Acupuncture for Pain in the Emergency Department","status":"WITHDRAWN","sponsor":"Loma Linda University","startDate":"2017-07-27","conditions":"Musculoskeletal Pain, Pain","enrollment":""},{"nctId":"NCT00385684","phase":"PHASE4","title":"Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2007-10","conditions":"Alzheimer Disease, Dementia, Dementia, Vascular","enrollment":11},{"nctId":"NCT00583869","phase":"EARLY_PHASE1","title":"Role of Pregabalin in Treatment of Post-Op Pain in Fracture Patients","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2007-05","conditions":"Post-operative Pain","enrollment":86}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["placebo with Lortab PRN"],"phase":"marketed","status":"active","brandName":"placebo with hydrocodone/APAP PRN","genericName":"placebo with hydrocodone/APAP PRN","companyName":"VA Office of Research and Development","companyId":"va-office-of-research-and-development","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Hydrocodone is an opioid agonist that binds to mu opioid receptors in the central nervous system to reduce pain perception, while acetaminophen (APAP) inhibits prostaglandin synthesis to provide additional analgesic and antipyretic effects. Used for Moderate pain (acute or chronic pain conditions).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}